Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center
- 15 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 43 (5) , e702-e706
Abstract
Adolescent and young adult (AYA) patients with Ewing sarcoma have inferior survival compared with pediatric patients even when treated with similar regimens. Investigation into specific explanations is lacking. A retrospective chart review of Ewing sarcoma patients at a single institution was performed, and 104 patients were identified, 45 were 15 to 39 years of age (AYA cohort) and 59 younger than 15 years (pediatric cohort). AYA patients demonstrated more metastatic disease (50% vs. 24%, P=0.009), peripheral tumor location (64% vs. 41%, P=0.025), percentage of male patients (76% vs. 51%; P=0.010), and tumor size ≥5 cm (93% vs. 70%, P=0.016) than pediatric patients. Five-year overall survival was 77.7% and 53.0% and event-free survival was 68.7% and 40.6% for pediatric versus AYA, respectively. Similar rates of toxicity and chemotherapeutic dose adjustments were demonstrated. In this cohort, increased AYA patient mortality appears to be related to disease characteristics rather than treatment-related differences.Keywords
This publication has 10 references indexed in Scilit:
- Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and EtoposideThe Oncologist, 2019
- Challenges of Clinical Management of Adolescent and Young Adults With Bone and Soft Tissue SarcomaThe Cancer Journal, 2018
- Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 DecadesAmerican Journal of Clinical Oncology, 2018
- Treatment pathway of bone sarcoma in children, adolescents, and young adultsCancer, 2017
- Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaCancer, 2016
- Ewing SarcomaJournal of Pediatric Hematology/Oncology, 2016
- Ewing Sarcoma: Current Management and Future Approaches Through CollaborationJournal of Clinical Oncology, 2015
- Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program databaseCancer Epidemiology, 2015
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- Survival from adolescent cancerCancer Treatment Reviews, 2007